Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
I don’t remember seeing the attached RNS but it wouldn’t surprise me if this is where we will receive substantial income before other revenue streams kick in
http://www.genedriveplc.com/press-releases/first_commercial_shipments_to_sysmex.pdf
have a completely revamped website. There is no mention of Genedrive but I hope the PCR tests that are mentioned are ours!
https://divoc.health/
Testing is here to stay for the foreseeable future and I'm very confident that GDR will have a big part to play both here and elsewhere.
https://www.kentlive.news/news/kent-news/over-400-cases-mutant-indian-5395830
This week I will see my 55th FOMO Friday but still holding on tight to those golden tickets
GLA
Taken from the virtual FDA Town hall transcript 28/4
“ They remain focused on expanding access to testing. This includes primarily diagnostic tests at home and point of care tests, and also collection at home and as well as extremely high throughput central lab tests.”
The last bit has got GDR and BC written all over it!
Having read this article I’m not convinced we’ll get a good foothold in the Indian market but hoping for the best!
https://indianexpress.com/article/explained/covid-tests-rt-pcr-coronavirus-negative-result-7297329/
This is an interesting report in relation to HCV, showing GDRs product and prices
https://www.treatmentactiongroup.org/wp-content/uploads/2020/08/pipeline_HCV_diagnostics_2020.pdf
This is something that DB and DIVOC could have pursued last June!
"The CDSCO in a notification on June 1, 2020 stated that based on criteria recommended by Indian Council of Medical Research (ICMR) and in light of the COVID-19 pandemic, US FDA approved, including emergency use authorization and CE approved COVID-19 diagnostic kits by regulators of country of origin will be considered for approval for emergency use licensing as per Medical Devices Rules, 2017 and use in India by the central drug regulatory authority."
http://www.pharmabiz.com/NewsDetails.aspx?aid=126543&sid=1
I bought in exactly one year ago today and am still waiting patiently for approvals and sales and know it will come eventually so please don't see this as deramp! GLA
BC Life Sciences recruiting a sales Channel Development Manager for Africa. As one of our target markets, hopefully we'll see some sales there soon!
https://jobs.danaher.com/global/en/job/R1145315/Channel-Development-Manager-Sub-Saharah-Africa
This is an interesting article which has BC and Genedrive written all over it and shows the potential for PCR testing. In fact it does show BC as being one of the prominent players in the value chain!
https://www.pharmiweb.com/press-release/2021-02-23/polymerase-chain-reaction-pcr-technologies-market-size-2021-expected-to-reach-us-10-776-million-b
Q: What are FDA's priorities with respect to review of EUA requests for COVID-19 tests? (Updated 12/2/20)
A: We are currently in a different phase of the pandemic with respect to tests than we were previously, where many COVID-19 tests are now authorized. We prioritize review of EUA requests for tests taking into account a variety of factors, as discussed in the Emergency Use Authorization of Medical Products and Related Authorities Guidance, such as the public health need for the product and the availability of the product. We have, for example, prioritized review of EUA requests for tests where authorization would increase testing accessibility (e.g., point of care (POC) tests, home collection tests, and at-home tests) or would significantly increase testing capacity (e.g., tests that reduce reliance on test supplies and high-throughput, widely distributed tests).
I really am at a loss as to understand why FDA approval has not been granted yet, particularly in light of the last paragraph of the attached which the FDA published at the beginning of December
https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/covid-19-test-development-and-review-faqs-testing-sars-cov-2
Ferrero2310 - £1.72
LordPaul - £1.70
AC177 - £1.78
Technick - £1.90
Dadsbatty - £1.82
Axelrod - £2.58
Saint-tropez £3.67
Cwalsh - 175
Longrun - £4.12
Dr long - £2.23
Northeast14 - £2.35
MarkA8178 - £1.85
bigAl67 £2.96
Cando - £4.23
Terewok - £2.17
Pa11ma11 - 1.78
CHELMOCHASER 1.80
HawkesBay - £2.20
BobbyK - £2.75
A word of caution before people start buying more on the strength of that. The assessment has been shown as complete for many weeks. We are just waiting for the dossier review to be completed which seems to be taking an age!
@CWalsh
Doesn't seem to want to open. Try this one and scroll down to the 4th box on the right for tests under assessment
https://extranet.who.int/pqweb/vitro-diagnostics/coronavirus-disease-covid-19-pandemic-%E2%80%94-emergency-use-listing-procedure-eul-open
Latest update published yesterday. Still in dossier review but a further product code has been added this week so may take time for approval to come through.
https://extranet.who.int/pqweb/sites/default/files/documents/210209_eul_covid_19_ivd_update.pdf.
The original product code was ID-CoV2-01-LPC (Low Profile Version). The fast plate version( ID-CoV2-01-FPC) was added last month and now there is a further code ID-CoV2-01-BPC- whatever that is for. Shows its still going through the process though.
GLA
There is going to be such huge demand for testing in the States going forward. I'm really looking forward to seeing how GDR will help out with this.
https://www.msn.com/en-gb/news/world/uk-covid-variant-rapidly-spreading-in-us-and-doubling-every-10-days-study-says/ar-BB1dvhwc?ocid=ACERDHP15&li=AAnZ9Ug
Incidentally I haven't seen any comments recently about DB's bonus. That's because it will look like loose change in comparison to revenue from future sales! IMO